Drug
Vinflunine clinical trials
- studies test it
- 22
- open now
- 0
- in phase 3
- 8
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
- Javlor
- 10
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2007 (6)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 6 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 13
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 9
Pierre Fabre Medicament (6) · Bristol-Myers Squibb (5) · SCRI Development Innovations, LLC (2) · Dr Anders Ullén (2) · Janssen Research & Development, LLC (1) · Institute of Cancer Research, United Kingdom (1) · Spanish Oncology Genito-Urinary Group (1) · Veeda Oncology (1)
Often tested with
Tested in the same studies.
Capecitabine (2) · Gemcitabine (2) · Erdafitinib (1) · Docetaxel (1) · Pembrolizumab (1) · Sorafenib (1) · Ixabepilone (1) · Carboplatin (1)
Studies
Open first, then newest update. How each study uses vinflunine is read from its arms, and is right about nine times in ten.
Testing it · 22
- A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsActive, not recruitingPhase 3Janssen Research & Development, LLCNCT03390504Written as Vinflunine
- Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01095003Written as Vinflunine plus Capecitabine
- Vinflunine in Hormone Refractory Prostate Cancer (HRPC)CompletedPhase 2SCRI Development Innovations, LLCNCT00545766Written as Vinflunine
- A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)CompletedPhase 2Institute of Cancer Research, United KingdomNCT02057913Written as Vinflunine
- A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionCompletedPhase 2Dr Anders UllénNCT02665039Written as Vinflunine
- Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01091168Written as vinflunine
- A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedPhase 3Pierre Fabre MedicamentNCT02054338Written as Vinflunine+Gemcitabine
- Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedPhase 3Pierre Fabre MedicamentNCT01953003Written as vinflunine
- Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractCompletedPhase 1Dr Anders UllénNCT01844947Written as Vinflunine
- Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial CancerCompletedPhase 2Spanish Oncology Genito-Urinary GroupNCT01529411Written as Vinflunine
- Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedPhase 3Pierre Fabre MedicamentNCT02347332Written as Vinflunine
- Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)WithdrawnPhase 1/2Ligartis GmbHNCT02845050Written as Vinflunine
- Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedPhase 2UNC Lineberger Comprehensive Cancer CenterNCT00519831Written as vinflunine
- Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnPhase 2Alliance for Clinical Trials in OncologyNCT00450515Written as vinflunine
- A Study of the Alternative Administration of Ixabepilone and VinflunineCompletedPhase 1Bristol-Myers SquibbNCT00362830Written as vinflunine + ixabepilone
- JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinCompletedPhase 2Pierre Fabre MedicamentNCT01599013Written as Vinflunine, Gemcitabine
- First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based TherapyCompletedPhase 2/3Bristol-Myers SquibbNCT00389155Written as Vinflunine
- A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced CancerWithdrawnPhase 1Bristol-Myers SquibbNCT00534807Written as Vinflunine
- Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung CancerCompletedPhase 2SCRI Development Innovations, LLCNCT00284154Written as Vinflunine
- A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung CancerCompletedPhase 2Veeda OncologyNCT00251446Written as Vinflunine
See all 22 studies that test vinflunine →
Given in every arm · 2 — vinflunine is usual care beside what is tested
- Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast CancerCompletedPhase 2SCRI Development Innovations, LLCNCT00284180Written as Vinflunine
- Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedPhase 1UNC Lineberger Comprehensive Cancer CenterNCT00320073Written as vinflunine
As the comparator · 6 — what is tested is compared with vinflunine
- A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)RecruitingPhase 3Merck Sharp & Dohme LLCNCT07419295Written as Vinflunine
- Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadCompletedPhase 3Gilead SciencesNCT04527991Written as Vinflunine
- A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)CompletedPhase 3Astellas Pharma Global Development, Inc.NCT03474107Written as Vinflunine
- A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)CompletedPhase 3Merck Sharp & Dohme LLCNCT02256436Written as vinflunine
- A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]CompletedPhase 3Hoffmann-La RocheNCT02302807Written as Vinflunine
- Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)Status unknownPhase 2/3Associació per a la Recerca Oncologica, SpainNCT01830231Written as Vinflunine
Codes
What other systems call vinflunine · ClinicalTrials.gg INT004056
- MeSH (NLM) C111217vinflunineConfirmed NLM, Wikidata
- UNII (FDA) 5BF646324KVINFLUNINEConfirmed FDA, NLM, Wikidata
- Wikidata Q2195393vinflunineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61564VinflunineOne source FDA
- DrugBank DB11641One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C111217 | vinflunine | Confirmed NLM, Wikidata |
| UNII (FDA) | 5BF646324K | VINFLUNINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2195393 | vinflunine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61564 | Vinflunine | One source FDA |
| DrugBank | DB11641 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.